Original articlesBrain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635
Section snippets
Subjects
Ten patients (eight men and two women) with chronic fatigue syndrome were recruited from an established CFS referral clinic at King-s College Hospital, London (Table 1). All clinic attenders were assessed using a thorough semistructured examination (Sharpe et al 1997a) at initial consultation to evaluate CFS and the presence of additional psychiatric disorder. Patients were included if they fulfilled both international consensus criteria for CFS (i.e., the Oxford criteria; Sharpe et al 1991)
Binding potential
To explore the effects of subject group and region on BP measures, we entered all 41 ROI measurements (left and right values for 20 brain areas and the raphe nuclei) into a repeated-measures ANOVA with region as the within-subject factor and group as the between-subjects factor. To explore the effects of laterality, we entered only the 40 ROI measures that were bilateral (i.e., the raphe measure was excluded) and added laterality as an additional, binary, within subject factor; because this
Discussion
The main finding from this study is of a widespread reduction in BP values for [11C]WAY-100635 in a carefully selected group of medication-free patients with CFS and no current comorbid psychiatric disorder, including depression. This reduction was particularly marked in the hippocampus bilaterally. This is the first study to our knowledge that has used neuroimaging to measure 5-HT receptors in CFS.
The reduced BP observed with [11C]WAY 100635 suggests either a reduction in the number of 5-HT1A
References (44)
Physiopharmacological interactions between stress hormones and central serotonergic systems
Brain Res Rev
(1993)- et al.
Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
J Affect Disord
(1995) - et al.
Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndromePreliminary findings
Biol Psychiatry
(1992) - et al.
Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome
Psychoneuroendocrinology
(1997) - et al.
Serotonin type-1A receptor imaging in depression
Nucl Med Biol
(2000) - et al.
PET imaging of serotonin 1A receptor binding in depression
Biol Psychiatry
(1999) - et al.
Tracer kinetic modelling of the 5-HT1A receptor ligand [carbony]-[11C]WAY-100635 for PET
Neuroimage
(1998) - et al.
Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome
J Neurol Sci
(1999) - et al.
Assessment of spatial normalization of PET ligand images using ligand specific templates
Neuroimage
(1999) - et al.
PET measurement of the influence of corticosteroids on serotonin-1A receptor number
Biol Psychiatry
(2001)
A Database of [11C]WAY-100635 binding to 5-HT1A receptors in normal male volunteersNormative data and relationship to methodological, demographic, physiological, and behavioral variables
Neuroimage
Chronic fatigue syndrome. A practical guide to assessment and management
Gen Hosp Psychiatry
Increased prolactin response to buspirone in chronic fatigue syndrome
J Affect Disord
Derivation of [(11)C]WAY-100635 binding parameters with reference tissue modelsEffect of violations of model assumptions
Nucl Med Biol
Physical activity in chronic fatigue syndromeassessment and its role in fatigue
J Psychiatr Res
Post infectious fatigueA prospective study in primary care
Lancet
Decreased 5-HT1A receptor binding in amygdala of schizophrenia
Biol Psychiatry
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome
BMJ
Persistent reduction in brain serotonin(1A) receptor binding in recovered depressed men measured by positron emission tomography with [(11)C]WAY-100635
Mol Psychiatry
Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue
Acta Physiol Scand
Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome
Br J Radiol
Lower hippocampal volume in patients suffering from depressionA meta-analysis
Am J Psychiatry
Cited by (100)
The historical progression of positron emission tomography research in neuroendocrinology
2023, Frontiers in NeuroendocrinologyResearch progress on central mechanism of acupuncture treatment for chronic fatigue syndrome
2023, World Journal of Acupuncture - MoxibustionFatigue in hypokinetic, hyperkinetic, and functional movement disorders
2021, Parkinsonism and Related DisordersApplications, Advances, and Limitations of Molecular Imaging of Brain Receptors
2021, Molecular Imaging: Principles and PracticeAssociation of HTR2A-1438G/A Genetic Polymorphism With Smoking and Chronic Obstructive Pulmonary Disease
2019, Archivos de BronconeumologiaCitation Excerpt :The A allele of rs6311 increases promotor activity, mRNA expression and protein levels and increases receptor binding.29,30 This promoter polymorphism supports an hyperactive serotonergic system.31 In addition, Falkerlber et al. suggested that the promoter polymorphism (rs6311) can affect both transcription factor binding and promoter methylation, and this along with an individual's stress response can impact the rate of HTR2A transcription in a genotype and methylation-dependent manner.32